Christopher Lacenere, Ph.D.

Partner

t:: 617-443-9292, ext 272
f:: 617-443-0004
e:: clacenere@sunsteinlaw.com

Suffolk University Law School: J.D., cum laude
California Institute of Technology: Ph.D., Biology
Carnegie Mellon University: B.S., Biological Sciences, with Honors

Communicating with Sunstein LLP through the website does not create an attorney-client relationship with the firm or any of our attorneys. Our decision as to whether we agree to represent a client involves consideration of a variety of factors, discussion with a prospective client, and, where appropriate, a written agreement.

Awards

Practice Areas

Patent Practice

Education

Suffolk University Law School J.D., cum laude
California Institute of Technology Ph.D., Biology
Carnegie Mellon University B.S., Biological Sciences, with Honors

View Christopher’s:

Chris concentrates his practice in the life sciences and has experience in genetics, cellular and molecular biology, and molecular diagnostics. He has worked on innovations in a wide array of fields, including gene editing, prime editing, genetically modified crops, antibodies, protein-drug conjugates, RNA interference, biologicals, oligonucleotide therapeutics, and medical devices. In addition to the life sciences, Chris has also managed portfolios and prosecuted patents on rotary engines, concentrated alcoholic beverages, and semiconductor manufacture.

He has extensive experience working with start-ups and universities, focusing on patent portfolio management, strategy, due diligence, and patent prosecution. Chris makes his clients' long-term business goals his top priority, drawing on his experience in industry and complex life sciences patent litigation.

Experience

In addition to patent prosecution, Christopher also has patent litigation experience, and has worked with litigators and expert witnesses on the technical aspects of patent litigation, claim construction, patent invalidity, and infringement.
Christopher’s doctoral research included the development of new nucleic acid sequencing technologies.
Christopher also has industry experience in validating the bioactivity of therapeutic drug candidate leads and evaluating high–throughput screening technologies.

Affiliations & Honors

Alan D. Lourie Boston Intellectual Property Inn of Court, Member
Recognized in Massachusetts Rising Stars, published by Super Lawyers, 2022-2024

Publications

Lacenere C, Garg MK, Stoltz BM, Quake SR. “Effects of a modified dye-labeled nucleotide spacer arm on incorporation by thermophilic DNA polymerases.” Nucleos Nucleot Nucl. 25:9-15 (2006).
Garg NK, Woodroofe CC, Lacenere CJ, Quake SR, Stoltz BM. “A ligand-free solid-supported system for Sonogashira couplings: applications in nucleoside chemistry.” Chem Comm. 36:4551-3 (2005).
Lacenere CJ, Sternberg PW. “Regulation of EGF receptor signaling in the fruitfly D. melanogaster and the nematode C. elegans.” Breast Dis. 11:19-30 (2000).